Delivery Order SPE2DB25D7067-SPE2DB25FSUNF

Award Date 2/21/25
Potential Completion Date 2/24/25
Potential Value $7.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,381.11 delivery order contract is for the supply of RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product. The contract has an ultimate completion date of January 22, 2025 and is a firm fixed price arrangement. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The federal contract award provides Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a Delivery Order valued at $30,687.90 to supply 4,566,487,325 units of Rifampin 300 mg capsules to the Defense Logistics Agency (DLA). This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) to provide RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product. The $2,289.52 firm fixed-price delivery order has a completion date of May 23, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,981.65 firm-fixed-price delivery order contract is for the supply of 4564885228 - RIFAMPIN 300 MG CAPSULE 60S. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,228.34 firm fixed-price delivery order is for the supply of 4563080820 - RIFAMPIN 300 MG CAPSULE UD 100S, with a performance period through December 13, 2023. No set-aside designation was used for this award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,403.03, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4562537982 RIFAMPIN 300 MG CAPSULE 60S, a medical supply item, with an ultimate completion date of October 20, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide 4564731036 RIFAMPIN 300 MG CAPSULE 60S. The contract has a ceiling value of $11,453.75 and an ultimate completion date of May 29, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of 4,567,279,694 units of RIFAMPIN 300 MG CAPSULE 30S to the Defense Logistics Agency (DLA). The contract, valued at $4,791.36, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,273.92 firm fixed-price delivery order is for the supply of RIFAMPIN 150 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,366.09 firm fixed-price delivery order is for the supply of 60 capsules of Rifampin 300 mg, a medication used to treat certain bacterial infections. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB25D7067
    Indefinite Delivery Contract
  • SPE2DB25D7067-SPE2DB25FSUNF
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,110.28, is a Firm Fixed Price Delivery Order for the supply of RIFAMPIN 300 MG CAPSULE 60S, a generic pharmaceutical product. The contract has an ultimate completion date of February 24, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract award was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has a significant history of federal contract awards, particularly with the DLA, to supply a wide array of pharmaceutical and medical products to support military and other federal healthcare programs.

Generated 5/23/25, 9:59 AM